Luks Group (Vietnam Holdings) Valuation
Is LU4 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of LU4 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: LU4 (€0.08) is trading below our estimate of fair value (€0.47)
Significantly Below Fair Value: LU4 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for LU4?
Key metric: As LU4 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is LU4's PS Ratio? | |
|---|---|
| PS Ratio | 1x |
| Sales | HK$401.44m |
| Market Cap | HK$391.91m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does LU4's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.7x | ||
STO3 Sto SE KGaA | 0.4x | 1.8% | €730.0m |
IBU IBU-tec advanced materials | 0.6x | 19.2% | €30.7m |
BNN BRAIN Biotech | 1.3x | 8.5% | €70.8m |
DLX Delignit | 0.3x | 10.2% | €24.4m |
LU4 Luks Group (Vietnam Holdings) | 1x | n/a | €391.9m |
Price-To-Sales vs Peers: LU4 is expensive based on its Price-To-Sales Ratio (1x) compared to the peer average (0.7x).
Price to Sales Ratio vs Industry
How does LU4's PS Ratio compare vs other companies in the European Basic Materials Industry?
| 0 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: LU4 is good value based on its Price-To-Sales Ratio (1x) compared to the European Basic Materials industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is LU4's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate LU4's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Stanmore Resources
AU$2.8b
Engages in the exploration, development, production, and sale of metallurgical coal in Australia.
S0D
AU$1.88
7D
0.5%
1Y
-16.8%
Tokuyama
JP¥197.6b
Produces and sells various chemical products in Japan.
TBT
JP¥16.70
7D
5.0%
1Y
16.0%
Mitsubishi Chemical Group
JP¥1.2t
Provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally.
M3C
JP¥5.27
7D
2.9%
1Y
-8.1%